
Andrew Serghios Barbas MD
Hepatobiliary Surgery, Pancreas, Transplantation
Associate Professor, Division of Abdominal Transplant Surgery, Duke University Medical Center
Join to View Full Profile
2301 Erwin RdDurham, NC 27705
Phone+1 919-684-8111
Dr. Barbas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of TorontoFellowship, 2014 - 2016
- Duke University HospitalResidency, Surgery, 2007 - 2014
- Duke University School of MedicineClass of 2007
Certifications & Licensure
- NC State Medical License 2007 - 2026
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- Adeno-associated virus-mediated transduction of PD-L1 in a rodent lung transplant model.Riley Kahan, Isaac S Alderete, Qimeng Gao, Benjamin Hughes, Min Zhang
American Journal of Transplantation. 2025-10-01 - Immunological Rejection in a Heterotopic Rat Liver Transplant Model.Camryn Thompson, Bret Verhoven, Min Zhang, Weifeng Zeng, Isaac Alderete
Transplantation Proceedings. 2025-10-01 - Acoustofluidic system for targeted antibody removal in transplantation: Enabling small-volume therapeutic apheresis.Zhiteng Ma, Riley Kahan, Jianping Xia, Mengxi Wu, Brandon Lu
Science Advances. 2025-09-05
Journal Articles
- Improved Contemporary Outcomes of Liver Transplantation for Pediatric Hepatoblastoma and Hepatocellular CarcinomaBrian Ezekian, Brian F Gilmore, Harold J Leraas, Stuart J Knechtle, Andrew S Barbas, Brian C Gulack, Alisha M Mavis, Susan G Kreissman, Michael S Mulvihill, Paul M Sch..., Pediatric Transplantation
Grant Support
- Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectorsDUKE UNIVERSITY2022–2027
- Platform for Extended Kidney Preservation Via Subnormothermic PerfusionBIOMEDINNOVATIONS, INC.2024–2026
- Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patternsDUKE UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: